[1] |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424.
DOI
URL
|
[2] |
BROOKS R A, FLEMING G F, LASTRA R R, et al. Current recommendations and recent progress in endometrial cancer[J]. CA Cancer J Clin, 2019,69(4):258-279.
|
[3] |
ANASTASIADOU E, JACOB L S, SLACK F J. Non-coding RNA networks in cancer[J]. Nat Rev Cancer, 2018,18(1):5-18.
DOI
URL
|
[4] |
RUPAIMOOLE R, SLACK F J. MicroRNA therapeutics:towards a new era for the management of cancer and other diseases[J]. Nat Rev Drug Discov, 2017,16(3):203-222.
DOI
URL
|
[5] |
YAO R W, WANG Y, CHEN L L. Cellular functions of long noncoding RNAs[J]. Nat Cell Biol, 2019,21(5):542-551.
DOI
URL
|
[6] |
SALMENA L, POLISENO L, TAY Y, et al. A ceRNA hypojournal:the Rosetta Stone of a hidden RNA language?[J]. Cell, 2011,146(3):353-358.
DOI
URL
|
[7] |
XIA L, WANG Y, MENG Q, et al. Integrated bioinformatic analysis of a competing endogenous RNA network reveals a prognostic signature in endometrial cancer[J]. Front Oncol, 2019,9:448.
DOI
URL
|
[8] |
LI R, QU H, WANG S, et al. GDCRNATools:an R/Bioconductor package for integrative analysis of lncRNA,miRNA and mRNA data in GDC[J]. Bioinformatics, 2018,34(14):2515-2517.
DOI
URL
|
[9] |
LI J H, LIU S, ZHOU H, et al. StarBase v2. 0:decoding miRNA-ceRNA,miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data[J]. Nucleic Acids Res, 2013,42(Database issue):D92-D97.
DOI
URL
|
[10] |
JEGGARI A, MARKS D S, LARSSON E. MiRcode:a map of putative microRNA target sites in the long non-coding transcriptome[J]. Bioinformatics, 2012,28(15):2062-2063.
DOI
URL
|
[11] |
CHOU C H, SHRESTHA S, YANG C D, et al. MiRTarBase update 2018:a resource for experimentally validated microRNA-target interactions[J]. Nucleic Acids Res, 2018,46(D1):D296-D302.
DOI
URL
|
[12] |
FURIÓ-TARÍ PEDRO, TARAZONA S, GABALDÓN TONI, et al. SpongeScan:a web for detecting microRNA binding elements in lncRNA sequences[J]. Nucleic Acids Res, 2016,44(W1):W176-W180.
DOI
URL
|
[13] |
YU G, WANG L G, HAN Y, et al. ClusterProfiler:an R package for comparing biological themes among gene clusters[J]. OMICS, 2012,16(5):284-287.
DOI
URL
|
[14] |
DONG P, XIONG Y, YUE J, et al. Exploring lncRNA-mediated regulatory networks in endometrial cancer cells and the tumor microenvironment:advances and challenges[J]. Cancers(Basel), 2019,11(2):234.
|
[15] |
CHEN Y, BI F, AN Y, et al. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer[J]. J Cell Biochem, 2019,120(9):14444-14454.
DOI
URL
|
[16] |
JIANG L, MENG W, ZENG J, et al. MiR-34c oligonucleotide enhances chemosensitivity of Ishikawa cell to cisplatin by inducing apoptosis[J]. Cell Biol Int, 2013,37(6):577-583.
DOI
URL
|
[17] |
LI F, CHEN H, HUANG Y, et al. MiR-34c plays a role of tumor suppressor in HEC-1-B cells by targeting E2F3 protein[J]. Oncol Rep, 2015,33(6):3069-3074.
DOI
URL
|
[18] |
YE W, XUE J, ZHANG Q, et al. MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A[J]. Oncol Rep, 2014,32(3):1193-1199.
DOI
URL
|
[19] |
HU Y, WU A Y, XU C, et al. MicroRNA-449a inhibits tumor metastasis through AKT/ERK1/2 inactivation by targeting steroid receptor coactivator(SRC) in endometrial cancer[J]. J Cancer, 2019,10(2):547-555.
|
[20] |
SOHN W J, KIM J Y, KIM D, et al. Expression and characterization of transmembrane and coiled-coil domain family 3[J]. BMB Rep, 2016,49(11):629-634.
DOI
URL
|